High-dose chemotherapy with autologous stem cell support for first-line treatment of aggressive non-Hodgkin lymphoma: a systematic review and meta-analysis based on individual patient data

This review has been withdrawn.

The reason for withdrawal and previous versions are archived and accessible within the withdrawn record in the Cochrane Library.

Health topics:

Cancer > Haematological malignancies > Non-Hodgkin’s lymphoma

Cancer > Haematological malignancies > Stem cell transplantation

Published:

9 December 2016

Authors:

Brillant C, Skoetz N, Kluge S, Schwarzer G, Trelle S, Greb A, Schulz H, Engert A, Bohlius J

Was this helpful? Donate.

If you found this evidence helpful, please consider donating to Cochrane. We are a charity that produces accessible evidence to help people make health and care decisions.
Donate
Print
PDF
Citation
Brillant C, Skoetz N, Kluge S, Schwarzer G, Trelle S, Greb A, Schulz H, Engert A, Bohlius J. High-dose chemotherapy with autologous stem cell support for first-line treatment of aggressive non-Hodgkin lymphoma: a systematic review and meta-analysis based on individual patient data. Cochrane Database of Systematic Reviews 2016, Issue 12. Art. No.: CD007580. DOI: 10.1002/14651858.CD007580.pub2